First Friday Bioscience Seminar Series: Pfenex Inc.’s evolution from a platform technology to a product development company
Join scientists and executives from local biomedical companies for the North Shore Technology Council’s First Friday Bioscience seminar series, sponsored by the Biomedical Technology Section. In this informal venue you will meet industry peers, learn about the science behind area biomedical companies, and hear how they tackle business challenges. You’ll also connect with other scientists and executives and become part of a community of business neighbors who are committed to accelerating the growth of their companies and the region biomedical business sector.
Presentation: An overview of Pfenexs evolution from a platform protein expression technology company to a product development company spurring value growth through a diversity of commercial approaches We will discuss how multiple funding sources, resource allocation, and differentiation enabled this transformation.
Offices of McLane Law Firm
300 TradeCenter, 7th Floor
Woburn MA USA
Date and Time
Begins: 10/04/2013 12:30 PM
Ends: 10/04/2013 02:00 PM
Patrick Lucy, Vice President Business Development and Marketing,
Patrick Lucy is the Vice President of Business Development and Marketing at Pfenex Inc., a biotechnology company leveraging its platform protein production technology for the development of biosimilars and novel vaccine products. In addition to the core focus of the company Pfenex also maintains a strain engineering service business and reagent protein catalog business.
Mr. Lucy was one of the founders of the company and played a leadership role on the original team that developed Pfēnex Expression Technology. He played a significant role in spinning the company out of The Dow Chemical Company via a Series A financing in 2009. He has led the negotiation and completion of numerous technology partnering, licensing, manufacturing and collaboration agreements with the US Federal Government and with large and small biopharmaceutical companies worldwide. Mr. Lucy is experienced in the areas of alliance management, licensing, intellectual property, biopharmaceutical operations, and biopharmaceutical facility design, construction and validation.
Mr. Lucy has been in the biotechnology industry for over twenty two years and was previously employed by Collaborative BioAlliance, Inc., The Dow Chemical Company, Lonza Biologics, Celltech Biologics and Repligen Corporation.
Mr. Lucy holds a B.S. in Biology from Villanova University
Headquartered in San Diego, California, Pfenex Inc. is a biotechnology company leveraging the proprietary Pfēnex Expression Technology platform for the development of biosimilars and innovative vaccines to address unmet and growing global healthcare needs. www.pfenex.com
United States Biological (USB) is a primary brand for the Life Science Industry and supplies 350,000+ antibodies, biochemicals, research kits and cell culture media.
UBS sells a full menu of products, such as, Agar, Agarose, Amino Acids, Antibiotics, Antibodies, Biochemicals, Carbohydrates, Cell Culture, Bacterial and Yeast Media, Enzymes, Peptides, Human & Animal Sera, Molecular Biology Reagents, Purification and Separation Media, Assay Kits, Magnetic Kits, Metabolite Screen Kits and ELISA Kits.
USB also provides custom services: Antibody Production and Conjugation, Protein and Enzyme Manufacturing, Peptide Synthesis, Mimetic Metabolite Screening and Production.
USB is known for their hot chilies and hot prices. United States Biological has one primary goal and that is “Reducing the cost of research!” through competitive pricing and product selection.
Warren Shore, President
For more information, click on the company logo above
Online registration closes at 5 p.m. the day before this event, October 3rd
Please register in advance – the Bioscience Committee tries to order the right amount of food. At our last meeting, we had many “door registrations” and ran out of food. At the previous meeting, we had many who registered and didn’t make it, and had a lot of left over food. If you need to cancel your registration, you may contact us at firstname.lastname@example.org prior to the event deadline, 5 p.m. the day before the seminar. Thank you.
Add to my Outlook Calendar
Add to my iCal Calendar
Add to my Google Calendar
http://www.google.com/calendar/event?action=TEMPLATE&text=First Friday Bioscience Seminar Series: Pfenex Inc.’s evolution from a platform technology to a product development company&dates=20131004T163000Z/20131004T180000Z&sprop=null&details=Details: https://www.123signup.com/event?id=dxxgx